Create Alert
Watchlist

Pfizer

₹5,097.60
-3.10 (0.06%) 1D
NSE
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this

Performance

Open
5,065.00
Prev. Close
5,100.70
Volume
19,033
Total traded value
9.70 Cr
Upper Circuit
6,117.10
Lower Circuit
4,078.10

Fundamentals

Market Cap₹23,328Cr
ROE18.36%
P/E Ratio(TTM)27.79
EPS(TTM)183.46
P/B Ratio6.06
Dividend Yield3.24%
Industry P/E39.81
Book Value841.20
Debt to Equity0.01
Face Value10
Understand Fundamentals

Financials

*All values are in Rs. Cr
No Graph Data To Display
Quarterly
Yearly

About Pfizer

For 75 years, Pfizer India has been a pivotal part of the nation's healthcare journey, shaping its pharmaceutical capabilities and serving millions of people since 1950. The company's core mission is to bring breakthroughs that change patients’ lives, reflecting a legacy of progress built on scientific excellence, compassion, and unwavering commitment to patients. It has consistently evolved alongside the country, walking with healthcare providers and communities with the primary goal of advancing the health and well-being of the Indian population. Pfizer pioneered the local manufacturing of anti-diabetic medication and anti-tuberculosis drugs, and later led advancements in antibiotics, establishing many trusted household brands across the country. The company deepens its market reach through a combination of scientific education for medical professionals, strong on-ground distribution, and effective digital engagement strategies across its portfolios. Its key product, Eliquis, successfully reached over three times more patients despite facing competition from around 100 affordably priced generic alternatives in the market.;
Parent OrganisationPfizer Limited
Managing DirectorMeenakshi Nevatia
Founded1950
NSE SymbolPFIZER

Shareholding Pattern

Sep '24
Dec '24
Mar '25
Jun '25
Sep '25
Promoters
63.92%
Retail And Others
16.37%
Mutual Funds
11.74%
Other Domestic Institutions
5.37%
Foreign Institutions
2.60%

Similar Stocks

COMPANY
52 WEEK
MARKET PRICE
P/E Ratio
Abbott India
NA
(0.00%)
39.26
GlaxoSmithKline Pharmaceuticals
NA
(0.00%)
45.26
Astrazeneca Pharma India
NA
(0.00%)
113.92
Sanofi Consumer Healthcare India
NA
(0.00%)
48.71
2025
12
Nov
Quarterly Result
Release date
13
Aug
Quarterly Result
Release date

9
Jul
Dividend
Ex date
₹35.00
per share

For each share you hold, you will receive ₹35.00
Dividend amount₹35.00 per share
Dividend TypeFinal
Ex Date9 Jul ‘25
Record Date9 Jul ‘25
Announcement date19 May ‘25

9
Jul
Dividend
Ex date
₹30.00
per share

For each share you hold, you will receive ₹30.00
Dividend amount₹30.00 per share
Dividend TypeSpecial
Ex Date9 Jul ‘25
Record Date9 Jul ‘25
Announcement date19 May ‘25

19
May
Dividend
Announced
₹35.00
per share

For each share you hold, you will receive ₹35.00
Dividend amount₹35.00 per share
Dividend TypeFinal
Ex Date9 Jul ‘25
Record Date9 Jul ‘25
Announcement date19 May ‘25

19
May
Dividend
Announced
₹30.00
per share

For each share you hold, you will receive ₹30.00
Dividend amount₹30.00 per share
Dividend TypeSpecial
Ex Date9 Jul ‘25
Record Date9 Jul ‘25
Announcement date19 May ‘25
19
May
Annual Result
Release date
31
Jan
Quarterly Result
Release date
2024
28
Oct
Quarterly Result
Release date

21
Aug
Dividend
Ex date
₹35.00
per share

For each share you hold, you will receive ₹35.00
Dividend amount₹35.00 per share
Dividend TypeFinal
Ex Date21 Aug ‘24
Record Date21 Aug ‘24
Announcement date17 May ‘24
29
Jul
Quarterly Result
Release date

17
May
Dividend
Announced
₹35.00
per share

For each share you hold, you will receive ₹35.00
Dividend amount₹35.00 per share
Dividend TypeFinal
Ex Date21 Aug ‘24
Record Date21 Aug ‘24
Announcement date17 May ‘24
17
May
Annual Result
Release date
Events calendar
View upcoming events in other stocks